The cutting-edge treatment that could lower dangerously high cholesterol [MSNBC.com]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: MSNBC.com
Christos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque that blood could no longer flow through them.It’s a surprisingly young age to need such a surgery, but extremelyhigh levels of cholesterolChristos Soteriou, left, with his son Jade. Soteriou has familial hypercholesterolemia, a genetic condition that causes extremely high cholesterol levels.Courtesy Jade SoteriouHe’s tried statins and a newer drug, Repatha, to lower his cholesterol, but nothing worked.So, when the opportunity came to join an early-stage clinical trial investigating a cutting-edge way to lower dangerously high cholesterol with a one-time treatment, he jumped at the chance.“I wasn’t too worried, because I’ll try anything at this point,” said Soteriou, from South Australia.The experimental treatment would useCRISPR, a gene-editing toolGene editing has emerged as a game-changing therapy for rare genetic diseases includingsickle cell diseaseWhen
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- A one-time treatment tweaked their genes — and lowered their cholesterol [MSNBC.com]MSNBC.com
- Assessing CRISPR Therapeutics (CRSP) Valuation As Recent Returns Send Mixed Signals [Yahoo! Finance]Yahoo! Finance
- The Personalized Biotech Flywheel Cathie Wood Built Is Still a Winning Bet Today [Yahoo! Finance]Yahoo! Finance
- CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- I Expect Crispr Therapeutics To Break Out As 2026 Revenue Exceeds Expectations [Seeking Alpha]Seeking Alpha
CRSP
Earnings
- 2/12/26 - Miss
CRSP
Sec Filings
- 4/2/26 - Form PRE
- 3/24/26 - Form 4
- 3/24/26 - Form 4
- CRSP's page on the SEC website